論文

査読有り
2011年1月

Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach

BREAST CANCER
  • Masahiro Takada
  • ,
  • Hiroshi Terunuma
  • ,
  • Xuewen Deng
  • ,
  • Md. Zahidunnabi Dewan
  • ,
  • Shigehira Saji
  • ,
  • Katsumasa Kuroi
  • ,
  • Naoki Yamamoto
  • ,
  • Masakazu Toi

18
1
開始ページ
64
終了ページ
67
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s12282-010-0198-5
出版者・発行元
SPRINGER JAPAN KK

A suggestive case of metastatic disease from breast cancer is reported. The HER-2-positive tumor was refractory to several agents, including anti-HER-2 therapy, trastuzumab, and lapatinib. After re-induction of trastuzumab in combination with activated natural killer (NK) cell injection therapy, tumor markers decreased, and finally a synergistic effect of taxane and capecitabine led to treatment response. This case suggests that multidisciplinary therapy including an immunological approach might be a breakthrough in the treatment of refractory disease.

リンク情報
DOI
https://doi.org/10.1007/s12282-010-0198-5
J-GLOBAL
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201102276358806436
CiNii Articles
http://ci.nii.ac.jp/naid/10027894715
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/20354831
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000289303500011&DestApp=WOS_CPL
ID情報
  • DOI : 10.1007/s12282-010-0198-5
  • ISSN : 1340-6868
  • eISSN : 1880-4233
  • J-Global ID : 201102276358806436
  • CiNii Articles ID : 10027894715
  • PubMed ID : 20354831
  • Web of Science ID : WOS:000289303500011

エクスポート
BibTeX RIS